Close Menu

NEW YORK (GenomeWeb) – Quadrant Biosciences said today that it has been awarded a $330,000 grant from the National Institutes of Health to further refine and validate its epigenetic diagnostic test for autism spectrum disorder.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.